{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:29:58Z","timestamp":1783488598083,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.rbmo.2011.09.017","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T14:28:51Z","timestamp":1318861731000},"page":"6-22","source":"Crossref","is-referenced-by-count":60,"title":["Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS?"],"prefix":"10.1016","volume":"24","author":[{"given":"Jyotsna","family":"Pundir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sesh Kamal","family":"Sunkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"El-Toukhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacoub","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2011.09.017_b0005","unstructured":"Abuzeid, M.I., Mitwally, M., Abuzeid, Y.M., Bokhari, H., Ashraf, M., Diamond, M.P., 2010. Ovarian stimulation with long versus conventional protocol of GnRH antagonist in women with PCOD undergoing assisted reproduction: randomised trial. Oral abstract presentation, ESHRE Rome."},{"key":"10.1016\/j.rbmo.2011.09.017_b0015","doi-asserted-by":"crossref","unstructured":"Al-Inany, H.G., Youssef, M.A.F.M., Aboulghar, M., Broekmans, F., Sterrenburg, M., Smit, J., Abou-Setta, A.M., 2011. Gonadotrophinreleasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst. Rev, Issue 5. Art. No.: CD001750. doi:10.1002\/14651858.","DOI":"10.1002\/14651858"},{"key":"10.1016\/j.rbmo.2011.09.017_b0020","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception","volume":"19","author":"Al-Inany","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rbmo.2011.09.017_b0025","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/humrep\/17.4.874","article-title":"GnRH antagonist in assisted reproduction A Cochrane review","volume":"17","author":"Al-Inany","year":"2002","journal-title":"Human Reprod."},{"key":"10.1016\/j.rbmo.2011.09.017_b0030","first-page":"14","article-title":"A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF\/ICSI cycles","volume":"3","author":"Ashrafi","year":"2005","journal-title":"Iranian J. Reprod. Med."},{"key":"10.1016\/j.rbmo.2011.09.017_b0035","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/humrep\/dei475","article-title":"Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomised trial","volume":"21","author":"Babayof","year":"2006","journal-title":"Human Reprod."},{"key":"10.1016\/j.rbmo.2011.09.017_b0040","first-page":"84","article-title":"Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: A randomised, prospective, pilot study","volume":"50","author":"Bahceci","year":"2005","journal-title":"J. Reprod. Med. Obstet. Gynecologists"},{"key":"10.1016\/j.rbmo.2011.09.017_b0045","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jama.282.11.1083","article-title":"Measuring the quality of trials: the quality of scales","volume":"282","author":"Berlin","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.rbmo.2011.09.017_b0050","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/humrep\/deq080","article-title":"Maternal death related to IVF in the Netherlands 1984\u20132008","volume":"25","author":"Braat","year":"2010","journal-title":"Human Reprod."},{"key":"10.1016\/j.rbmo.2011.09.017_b0055","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1471-0528.1995.tb10840.x","article-title":"Diagnosis, prevention and management of ovarian hyperstimulation syndrome","volume":"102","author":"Brinsden","year":"1995","journal-title":"Brit. J. Obstet. Gynaecol."},{"key":"10.1016\/j.rbmo.2011.09.017_b0060","series-title":"Berek and Novak\u2019s Gynecology, 14th ed","first-page":"1253","article-title":"Infertility","author":"Burney","year":"2007"},{"key":"10.1016\/j.rbmo.2011.09.017_b0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.rbmo.2011.09.017_b0070","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.rbmo.2011.09.017_b0075","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1472-6483(10)60653-0","article-title":"GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS","volume":"13","author":"Engmann","year":"2006","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.rbmo.2011.09.017_b0080","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rbmo.2011.09.017_b0085","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","author":"Golan","year":"1989","journal-title":"Obstet. Gynecol. Surv."},{"issue":"\/5","key":"10.1016\/j.rbmo.2011.09.017_b0090","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S1472-6483(10)60652-9","article-title":"GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: A meta-analysis","volume":"13","author":"Griesinger","year":"2006","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.rbmo.2011.09.017_b0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/humupd\/dmi036","article-title":"A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome","volume":"12","author":"Heijnen","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2011.09.017_b0100","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.rbmo.2011.09.017_b0105","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0015-0282(16)56287-6","article-title":"In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome","volume":"60","author":"Homburg","year":"1993","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2011.09.017_b0110","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1447-0756.2010.01247.x","article-title":"Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients","volume":"36","author":"Hosseini","year":"2010","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.rbmo.2011.09.017_b0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.fertnstert.2010.03.028","article-title":"Preventing ovarian hyperstimulation syndrome: guidance for the clinician","volume":"94","author":"Humaidan","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2011.09.017_b0115","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2011.09.017_b0125","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/humrep\/deh375","article-title":"Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomised study","volume":"19","author":"Hwang","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2011.09.017_b0130","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/humrep\/den128","article-title":"; Quantification of the effect of pituitary down-regulation on 3D ultrasound predictors of ovarian response","volume":"23","author":"Jayaprakasan","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2011.09.017_b0135","first-page":"834","article-title":"Increased risk of earlypregnancy loss and lower live birth rate with GnRH antagonist vs long GnRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation","volume":"87","author":"Kdous","year":"2009","journal-title":"Tun. Med."},{"key":"10.1016\/j.rbmo.2011.09.017_b0140","first-page":"1060","article-title":"Use of GnRH antagonist (Cetrorelix) in controlled ovarian hyperstimulation in women with polycystic ovary disease","volume":"86","author":"Kdous","year":"2008","journal-title":"La. Tun. Med."},{"key":"10.1016\/j.rbmo.2011.09.017_b0145","unstructured":"Kim, C.H., Lee, Y.J., Hong, S.H., Nah, H.Y., Kim, S.H., Chae, H.D., Kang, B.M. (2004). Efficacy of a GnRH antagonist during early and late controlled ovarian hyperstimulation period in women with polycystic ovarian syndrome undergoing IVF-ET. Abstracts of 20th Annual meeting of ESHRE, Berlin."},{"key":"10.1016\/j.rbmo.2011.09.017_b0265","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humupd\/dml038","article-title":"Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis","volume":"12","author":"Kolibianakis","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2011.09.017_b0160","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","article-title":"A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists","volume":"20","author":"Kolibianakis","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2011.09.017_b0165","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10815-008-9249-7","article-title":"Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomised study","volume":"25","author":"Kurzawa","year":"2008","journal-title":"J. Assist. Reprod. Genetics"},{"key":"10.1016\/j.rbmo.2011.09.017_b0270","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/humrep\/dem033","article-title":"Initiation of GnRH antagonist on day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomised controlled trial: Effect on hormonal levels and follicular development","volume":"22","author":"Lainas","year":"2007","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2011.09.017_b0170","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/dep436","article-title":"Flexible GnRH antagonist protocol versus GnRH long agonist protocol in patients with polycystic ovary syndrome treated for IVF: A prospective randomised controlled trial (RCT)","volume":"25","author":"Lainas","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2011.09.017_b0175","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/bmj.322.7300.1479","article-title":"Forest plots: trying to see the wood and the trees","volume":"322","author":"Lewis","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.rbmo.2011.09.017_b0185","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.rbmo.2011.09.017_b0190","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/14647270701194143","article-title":"Odds of ovarian hyperstimulation syndrome (OHSS)\u2013time for reassessment","volume":"10","author":"Mocanu","year":"2007","journal-title":"Hum. Fertil. (Camb.)"},{"key":"10.1016\/j.rbmo.2011.09.017_b0195","first-page":"i120","article-title":"GnRH antagonist multiple-dose protocol during early, late follicular phase is effective in women with PCOS undergoning IVF-ET regardless of bmi","volume":"24","author":"Moon","year":"2009","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.rbmo.2011.09.017_b0200","first-page":"i121","article-title":"GnRH antagonist versus long GnRH agonists protocol in PCOS patients undergoing IVF treatment","volume":"22","author":"Moshin","year":"2007","journal-title":"Abstracts of the 23rd Annual Meeting of the ESHRE, Lyon, France"},{"key":"10.1016\/j.rbmo.2011.09.017_b0205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","article-title":"Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment","volume":"58","author":"Navot","year":"1992","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2011.09.017_b0210","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.fertnstert.2008.07.1711","article-title":"What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?","volume":"91","author":"Orvieto","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2011.09.017_b0215","first-page":"870","article-title":"Polycystic ovaries\u2013a common finding in normal women","volume":"16","author":"Polson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.rbmo.2011.09.017_b0220","series-title":"In Vitro Fertilization and Assisted Reproduction","first-page":"131","article-title":"Classification, pathophysiology and management of ovarian hyperstimulation syndrome","author":"Rizk","year":"1993"},{"key":"10.1016\/j.rbmo.2011.09.017_b0225","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/j.fertnstert.2007.07.621","article-title":"Can pregnancy rate be improved by addition of GnRH antagonist to gonadotropin stimulated cycles in women with polycystic ovary syndrome undergoing ovulation induction? A prospective randomised study","volume":"88","author":"Stadtmauer","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2011.09.017_b0230","doi-asserted-by":"crossref","first-page":"S314","DOI":"10.1016\/j.fertnstert.2005.07.820","article-title":"Impact of a GnRH antagonist (Ganirelix (R)) on the outcome of controlled ovarian hyperstimulation (COH) in PCOS patients: A prospective and randomised study","volume":"84","author":"Stadtmauer","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2011.09.017_b0235","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejogrb.2009.11.017","article-title":"IVF outcome in women with PCOS, PCO and normal ovarian morphology","volume":"149","author":"Swanton","year":"2010","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.rbmo.2011.09.017_b0240","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00404-010-1429-x","article-title":"Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients","volume":"282","author":"Tehraninejad","year":"2010","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.rbmo.2011.09.017_b0245","doi-asserted-by":"crossref","unstructured":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19, 41\u201347.","DOI":"10.1093\/humrep\/deh098"},{"key":"10.1016\/j.rbmo.2011.09.017_b0250","doi-asserted-by":"crossref","unstructured":"The Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2008). Consensus on infertility treatment related to polycystic ovary syndrome. Fertil. Steril. 89, 505\u2013522.","DOI":"10.1016\/j.fertnstert.2007.09.041"},{"key":"10.1016\/j.rbmo.2011.09.017_b0255","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1472-6483(10)60420-8","article-title":"Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS","volume":"18","author":"Vrtacnik-Bokal","year":"2009","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.rbmo.2011.09.017_b0260","unstructured":"Youssef, M., Griesinger, G., Van Wely, M., AL-Inany, H., Van Der Veen, F. (2009). Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist ART cycles. A systematic review and meta-analysis. Abstracts of the 25th Annual Meeting of ESHRE, Amsterdam."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648311005359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648311005359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T15:44:33Z","timestamp":1560786273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648311005359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1472648311005359"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2011.09.017","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}